Original from: Truvian Health
Truvian Health (“Truvian”), a diagnostics company transforming routine blood testing through its automated benchtop platform, today announced a strategic alliance withSiemens Healthineers to advance the TruVerus™ platform and explore opportunities to expand access to high-quality blood testing across a broader range of laboratory and healthcare settings.
The alliance brings together Truvian’s differentiated blood testing platform with Siemens Healthineers’ extensive capabilities in diagnostics, assay development, manufacturing, quality systems, and global commercialization. Siemens Healthineers will provide development support, technical resources, manufacturing expertise, and commercial guidance to support continued advancement of the TruVerus platform. The companies will also explore opportunities to develop and commercialize future diagnostic solutions.
“Partnering with Siemens Healthineers represents an important milestone for Truvian and strong validation of both the TruVerus platform and the market opportunity we are pursuing,” said Dena Marrinucci, PhD, Founder and Chief Operating Officer of Truvian Health. “Siemens Healthineers brings world-class experience developing, manufacturing, and commercializing diagnostic technologies at global scale. Bringing that expertise together with Truvian’s platform can help us accelerate development, expand our capabilities, and ultimately bring high-quality testing to a broader range of healthcare settings.”
Truvian developed TruVerus to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform. The system is designed to provide laboratory-quality results while enabling testing in a wider range of healthcare environments.
“The goal of our alliance is to expand patient access to testing. By combining Truvian’s innovative TruVerus platform with our diagnostics expertise and global reach, we see an opportunity to advance innovation and provide the right test, at the right time, in the most convenient way possible," said Dirk Heckel, Chief Technology Officer for Diagnostics, Siemens Healthineers.
The companies are focused on advancing diagnostic technologies that can make high-quality testing more accessible, efficient, and integrated into the way healthcare is delivered.
Copyright © 2026 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.